plerixafor has been researched along with Granuloma, Hodgkin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 25 (89.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alousi, A; Anderlini, P; Champlin, R; Ciurea, S; de Lima, M; Hosing, C; Kebriaei, P; Khouri, I; Nieto, Y; Popat, U; Qazilbash, M; Rondon, G; Smith, VR | 1 |
| Bilgin, YM; Croockewit, A; de Greef, GE; Gahar, RR; Visser, O | 1 |
| Bensinger, W; Copelan, E; Costa, L; Devine, S; Dipersio, J; Giralt, S; Hosing, C; Leather, H; Maziarz, R; McCarty, J; Negrin, R; Pazzalia, A; Petersen, FB; Rondelli, D; Schriber, J; Shaughnessy, P; Snyder, E; Soiffer, R | 1 |
| Carlo-Stella, C; Corradini, P; Farina, L; Guidetti, A; Longoni, P; Ravagnani, F; Roncari, L; Spina, F | 1 |
| Aksu, T; Demir, HA; Emir, S; Kara, A; Özgüner, M; Tunç, B | 1 |
| Bonferroni, M; Borra, A; Castellino, C; Celeghini, I; Di Marco, C; Fiore, F; Gallamini, A; Ghiglia, A; Grasso, M; Marenchino, D; Mattei, D; Mordini, N; Rapezzi, D; Sorasio, R; Strola, G | 1 |
| Kaniewski, M; Nademanee, A; Palmer, J; Shayani, S; Wang, S; Yuan, S | 1 |
| Arabi, A; Bekadja, MA; Bouhass, R; Brahimi, M; Osmani, S; Talhi, S; Yafour, N | 1 |
| Beckers, EA; Bilgin, YM; Croockewit, AJ; de Greef, GE; Huisman, C; Kramer, EP; Netelenbos, T; te Boome, LC; Visser, O; Ypma, PF | 1 |
| Danylesko, I; Nagler, A; Sareli, R; Shem-Tov, N; Shimoni, A; Varda-Bloom, N; Yerushalmi, R | 1 |
| Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
| Motalkina, MS | 1 |
| Craig, MD; Cumpston, A; D'Souza, A; Dhakal, B; Eastwood, D; Esselman, J; Fenske, TS; Hamadani, M; Hari, P; Kanate, AS; Pasquini, MC; Shillingburg, A; Veltri, LW; Watkins, K | 1 |
| Cashen, AF; Rettig, MP; Uy, GL | 1 |
| Badel, K; Calandra, G; Cashen, A; DiPersio, J; Gao, F; Lopez, S; MacFarland, R | 1 |
| Gaarsdal, E; Hansen, PB | 1 |
| Basak, GW; Dabrowska-Iwanicka, A; Dybko, J; Hawrylecka, D; Kisiel, E; Knopinska-Posluszny, W; Matuszak, M; Rzepecki, P; Szmigielska-Kaplon, A; Urbaniak-Kujda, D; Werkun, J; Wiktor-Jedrzejczak, W; Wroblewska, W; Zielinska, P | 1 |
| Albert, MH; Basara, N; Beier, R; Bogner, C; Christopeit, M; Dressler, S; Ebinger, M; Fresen, MM; Frickhofen, N; Galm, O; Hartwig, R; Heits, F; Hertenstein, B; Hübel, K; Kiehl, M; Kröger, N; Lange, F; Liebler, S; Lordick, F; Rösler, W; Salwender, H; Theurich, S; von Lilienfeld-Toal, M; Wehler, D; Weidmann, E; Weigelt, C; Zander, AR | 1 |
| Karakantza, M; Kouraklis, A; Liga, M; Spyridonidis, A; Symeonidis, A; Tiniakou, M; Triantafyllou, E; Zoumbos, N | 1 |
| Jantunen, E; Kuittinen, T; Mahlamäki, E; Mäntymaa, P; Nousiainen, T; Pyörälä, M | 1 |
| Basak, GW; Basic-Kinda, S; Cegledi, A; Giebel, S; Hübel, K; Jaksic, O; Koristek, Z; Labar, B; Masszi, T; Mayer, J; Mikala, G; Reti, M; Wiktor-Jedrzejczak, W | 1 |
| Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Lanza, F; Lemoli, R; Mikala, G; Mohty, M; Selleslag, D; Wiktor-Jedrzejczak, W; Worel, N | 1 |
| Apperley, JF; Basak, GW; Douglas, KW; Duarte, RF; Fresen, MM; Gabriel, IH; Geraldes, C; Hübel, K; Jaksic, O; Koristek, Z; Kröger, N; Lanza, F; Lemoli, RM; Mikala, G; Mohty, M; Selleslag, D; Worel, N | 1 |
| Forman, SJ; Nademanee, A; Wang, S; Yuan, S | 1 |
| Amico, I; Ancora, F; Bartolozzi, B; Bosi, A; Guidi, S; Iacopino, P; Irrera, G; La Fauci, A; Leotta, S; Martino, M; Milone, G; Nozzoli, C; Poidomani, M; Saccardi, R; Spadaro, A; Tripepi, G | 1 |
| Babic, A; Gardellini, A; Gigli, F; Laszlo, D; Liptrott, SJ; Martinelli, G | 1 |
| Armistead, PM; Brown, PM; Coghill, JM; Essenmacher, A; Gabriel, DA; Goyal, R; Irons, R; Rao, KV; Sarantopoulos, S; Serody, JS; Sharf, A; Shea, TC; Whitley, J; Wood, WA | 1 |
| Artz, A; Ball, ED; Berryman, R; Devine, S; Dugan, M; Hsu, FJ; Jacobsen, E; Johns, D; Joyce, R; Maziarz, RT; McCarty, J; McSweeney, P; Micallef, I; Shaughnessy, P; Stiff, P; Uberti, J; Vose, J | 1 |
4 review(s) available for plerixafor and Granuloma, Hodgkin
| Article | Year |
|---|---|
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.
Topics: Benzylamines; Cyclams; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma; Polyethylene Glycols; Recombinant Proteins; Survival Analysis; Transplantation, Autologous | 2014 |
Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
Topics: Anti-HIV Agents; Antigens, CD34; Benzylamines; Chemokine CXCL12; Clinical Trials as Topic; Cyclams; Drug Design; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Hodgkin Disease; Humans; Models, Chemical; Receptors, CXCR4; Stem Cell Transplantation | 2008 |
[Mobilisation of haematopoietic stem cells with plerixafor--secondary publication].
Topics: Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Multiple Myeloma | 2009 |
Successful mobilisation of peripheral blood stem cells in children using plerixafor: a case report and review of the literature.
Topics: Adolescent; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Stem Cell Transplantation; Transplantation, Autologous | 2013 |
9 trial(s) available for plerixafor and Granuloma, Hodgkin
| Article | Year |
|---|---|
Use of Plerixafor in patients that show failure of peripheral blood stem cell mobilization with G-CSF. Experience of three Dutch centers.
Topics: Anti-HIV Agents; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous | 2013 |
Use of plerixafor for peripheral blood stem cell mobilization failure in children.
Topics: Adolescent; Adult; Anti-HIV Agents; Autografts; Benzylamines; Child; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Male; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Sarcoma, Ewing | 2014 |
Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Biomarkers; Cyclams; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Time Factors; Transplantation, Autologous | 2014 |
Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study.
Topics: Adult; Aged; Anti-HIV Agents; Autografts; Benzylamines; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Receptors, CXCR4 | 2016 |
Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Benzylamines; Biopsy; Blood Glucose; Blood Transfusion; Cholesterol, LDL; Combined Modality Therapy; Cyclams; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Glycated Hemoglobin; Granulocyte Colony-Stimulating Factor; Hamstring Muscles; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Hydrazines; Immunohistochemistry; Insulin-Secreting Cells; Leg; Male; Middle Aged; Muscle Strength; Neoplasms; Peripheral Blood Stem Cell Transplantation; Range of Motion, Articular; Recurrence; Remission Induction; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Soccer; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Triazoles; Young Adult | 2015 |
A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antigens, CD34; Benzylamines; Blood Component Removal; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Hodgkin Disease; Humans; Male; Middle Aged; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program.
Topics: Adolescent; Adult; Aged; Benzylamines; Blood Component Removal; Child; Child, Preschool; Combined Modality Therapy; Compassionate Use Trials; Cyclams; Female; Germany; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Treatment Outcome; Young Adult | 2011 |
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Benzylamines; Blood Component Removal; Child; Cyclams; European Union; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Transplantation, Homologous | 2012 |
Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.
Topics: Adult; Aged; Anti-HIV Agents; Benzylamines; Blood Component Removal; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Time Factors; Transplantation, Autologous; United States | 2013 |
15 other study(ies) available for plerixafor and Granuloma, Hodgkin
| Article | Year |
|---|---|
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Cell Count; Cyclams; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Time Factors; Transplantation, Autologous; Treatment Outcome | 2013 |
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
Topics: Adult; Aged; Algorithms; Antigens, CD34; Antineoplastic Agents; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged | 2014 |
Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Blood Cell Count; Bone Marrow; Child; Combined Modality Therapy; Cyclams; Drug Evaluation; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Young Adult | 2014 |
Plerixafor in the treatment of progenitor cell mobilization failure: First experience in Algeria.
Topics: Adult; Algeria; Antigens, CD34; Benzylamines; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Receptors, CXCR4; Stem Cell Transplantation; Young Adult | 2015 |
Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factor.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multiple Myeloma; Netherlands; Retrospective Studies | 2015 |
[Combination of pegfilgrastim and plerixafor as an effective regimen of hematopoietic stem cells mobilization in cancer patients: own experience].
Topics: Adult; Aged; Antineoplastic Agents; Benzylamines; Blood Component Removal; Cyclams; Cyclophosphamide; Dexamethasone; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Polyethylene Glycols; Recombinant Proteins | 2015 |
Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Blood Transfusion; Carboplatin; Cyclams; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Young Adult | 2016 |
Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Cohort Studies; Compassionate Use Trials; Cyclams; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Poland; Receptors, CXCR4; Retrospective Studies; Transplantation, Autologous; Young Adult | 2011 |
Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease.
Topics: Adolescent; Benzylamines; Cyclams; Female; Gaucher Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans | 2011 |
Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cyclams; Female; Filgrastim; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Polyethylene Glycols; Receptors, CXCR4; Recombinant Proteins; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2011 |
Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Agents; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Transplantation, Autologous; Treatment Outcome; Young Adult | 2011 |
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
Topics: Adult; Aged; Aged, 80 and over; Benzylamines; Body Mass Index; Contraindications; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Obesity; Overweight; Retrospective Studies; Thinness; Young Adult | 2012 |
Use of plerixafor in patients with Hodgkin lymphoma with poor mobilization of peripheral blood stem cells.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Cell Count; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Hodgkin Disease; Humans; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Young Adult | 2013 |
Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor.
Topics: Adult; Aged; Anti-HIV Agents; Antigens, CD34; Benzylamines; Cyclams; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Hodgkin Disease; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous | 2013 |
Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Autografts; Benzylamines; Costs and Cost Analysis; Cyclams; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged | 2013 |